Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2006
04/13/2006WO2006037215A1 Expression system, components thereof and methods of use
04/13/2006WO2006021451A3 Methods and compounds for treating diabetes
04/13/2006WO2006011795A3 Method for preventing dehiscence and altering plant lignification
04/13/2006WO2006006074A3 Inhibitors based on fusion, hr1 and hr2 sequences in bacterial adhesin
04/13/2006WO2006002646A3 Novel carbamylated epo and method for its production
04/13/2006WO2005116255A3 Aptamer-toxin molecules and method for using same
04/13/2006WO2005095632A3 Methods for identifying proteins with starch phosphorylating enzymatic activity
04/13/2006WO2005094365A3 Ten-m3 polypeptides and polynucleotides and their methods of use
04/13/2006WO2005093429A3 Method for the detection of intracellular parameters with luminescent protein probes for the screening of molecules capable of altering said parameters
04/13/2006WO2005090602A3 Method for diagnosing or predicting susceptibility to optic nueropathy
04/13/2006WO2005083068A3 Methods for obtaining thermostable enzymes, dna polymerase i variants from thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications to the same
04/13/2006WO2005060328A3 ENCODING NUCLEOTIDES OF GENES FROM THE CHROMOSOME OF THE BACTERIUM Mycoplasma hyopneumoniae, EXPRESSION AND ACTIVITY OF THE POLYNUCLEOTIDES AND THEIR APPLICATIONS
04/13/2006WO2005047487A3 Motoneuronotrophic factor gene sequences
04/13/2006WO2005041758A3 Novel cell-based assays employing voltage and calcium dyes
04/13/2006WO2005032460A3 Human epo mimetic hinge core mimetibodies, compositions, methods and uses
04/13/2006WO2005028504A3 Regulation of tissue mineralization and phosphate met abolism by asarm peptides
04/13/2006WO2005019258A3 Compositions and methods for the treatment of immune related diseases
04/13/2006WO2005012876A3 Methods of screening compositions for g protein-coupled receptor desensitization inhibitory activity
04/13/2006WO2004104169A3 Identification and use of genes encoding holins and holin-like proteins in plants for the control of microbes and pests
04/13/2006WO2004003147A3 Cngh0004 polypeptides, antibodies, compositions, methods and uses
04/13/2006WO2003104404A3 Cancer-linked gene as target for chemotherapy
04/13/2006WO1995019374A9 Bacterial receptor structures
04/13/2006US20060080744 Novel chemokine-like polypeptides
04/13/2006US20060079675 Compositions and use of inflammation-20 (Inf-20) gene
04/13/2006US20060079674 Contraceptive targets
04/13/2006US20060079670 98 human secreted proteins
04/13/2006US20060079669 Crystal structures of NH3-dependent NAD synthetases
04/13/2006US20060079668 Junctional adhesion molecule splice variants
04/13/2006US20060079477 High affinity nucleic acid ligands of complement system proteins
04/13/2006US20060079475 Methods and compositions for modulating cardiac contractility
04/13/2006US20060079460 Purified LH
04/13/2006US20060079459 Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteins
04/13/2006US20060079455 Peptide nanostructures encapsulating a foreign material and method of manufacturing same
04/13/2006US20060079454 Peptide nanostructures and methods of generating and using the same
04/13/2006US20060079453 Hla binding peptides and their uses
04/13/2006US20060079452 Administering anakinra
04/13/2006US20060079451 Heparin-binding proteins modified with sugar chains, method of producing the same and pharmaceutical compositions containing same
04/13/2006US20060079445 CaMKII/calcium channel binding-related compositions and methods
04/13/2006US20060078992 protein biosynthesis inhibitor resistance genes capable of imparting cycloheximide resistance to animal cells sensitive to the inhibitor; genes have sequences mutated by substitution in a gene coding a ribosome-constituting protein derived from an animal; expression vectors; genetic engineering
04/13/2006US20060078981 Reducing branching and enhancing fragmentation in culturing filamentous microorganisms
04/13/2006US20060078980 Production of polyketides and other natural products
04/13/2006US20060078970 Fusion polypeptide suitable as a cytotoxin
04/13/2006US20060078969 Regulated transcription of targeted genes and other biological events
04/13/2006US20060078967 Antibodies for IL-17 receptor like polypeptides and uses thereof
04/13/2006US20060078966 IL-17 receptor like polypeptides and uses thereof
04/13/2006US20060078964 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/13/2006US20060078963 Methods for producing modified glycoproteins
04/13/2006US20060078962 Chitosan bound to residues of one or more polypeptides, at least one which has a tyrosine or glutamine residue; formed by reacting the peptides, chitosan and a transglutaminase or tyrosinase enzyme and allowing the chitosan to bind to the peptides; used for dressing wounds
04/13/2006US20060078950 Identification of Porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
04/13/2006US20060078947 Methods and compositions for treating hematological disorders using 9118, 990, 17662, 81982, 630, 21472, 17692, 19290, 21620, 21689, 28899, 53659, 64549, 9465, 23544, 7366, 27417, 57259, 21844, 943, 2061, 5891, 9137, 13908, 14310, 17600, 25584, 27824, 28469, 38947, 53003, 965, 56639, 9661, 16052, 1521, 6662, 13913, 12405 or 5014
04/13/2006US20060078944 Methods and reagents relating to inflammation and apoptosis
04/13/2006US20060078940 21132, a human G-protein coupled receptor family member and uses therefor
04/13/2006US20060078933 Identifying a modulator of IL-17 receptor-like polypeptide activity; drug screening; treating inflammation
04/13/2006US20060078932 Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes
04/13/2006US20060078918 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
04/13/2006US20060078909 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
04/13/2006US20060078901 Listeria monocytogenes genome, polypeptides and uses
04/13/2006US20060078884 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins
04/13/2006US20060078880 Zinc finger libraries
04/13/2006US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription
04/13/2006US20060078874 Use of nuclear hormone receptors
04/13/2006US20060078572 M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever
04/13/2006US20060078566 Antigen ORF Rv2430c and a method thereof
04/13/2006US20060078565 Nucleic acids and proteins from Group B Streptococcus
04/13/2006US20060078564 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
04/13/2006US20060078563 Using heat shock proteins to increase immune response
04/13/2006US20060078562 RAGE fusion proteins and methods of use
04/13/2006US20060078558 Diagnosis, prognosis and treatment of pulmonary diseases
04/13/2006US20060078557 Methods and compositions for promoting immunopotentiation
04/13/2006US20060078551 Polynucleotide that encodes a polypeptide having activity as a phospholipase A2 inhibitor; especially obtained from the liver of a species of Python
04/13/2006US20060078539 Remedies for tumor in hematopoietic organs
04/13/2006US20060078537 Mono-and dual chemokine/cytokine constructs
04/13/2006US20060078498 Methods for the identification of novel ligands for the g protein-coupled receptor (gpcr) 192
04/13/2006DE102004049479A1 Proteinkonjugate zur Verwendung in Therapie, Diagnose und Chromatographie Protein conjugates for use in therapy, diagnosis and chromatography
04/13/2006CA2615139A1 Piscirickettsia salmonis antigens and use thereof
04/13/2006CA2583431A1 Variant amyloid protein
04/13/2006CA2583220A1 Bioactive compositions, natural methods of producing them and computational methods for designing natural production processes
04/13/2006CA2583065A1 Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes
04/13/2006CA2582963A1 T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents
04/13/2006CA2582306A1 Covalent grafting of hydrophobic abustances on collagen
04/13/2006CA2581554A1 Hepatitis c virus replication system
04/13/2006CA2581048A1 Use of pregnancy specific glycoprotein for maturation of oocytes
04/13/2006CA2580969A1 Domain ii mutants of anthrax lethal factor
04/13/2006CA2580515A1 Expression system, components thereof and methods of use
04/13/2006CA2580426A1 Deglycosylated and desialidated long pentraxin ptx3
04/13/2006CA2579845A1 Devices and methods for integrated continuous manufacturing of biological molecules
04/13/2006CA2578573A1 Use of il-17- for maturation of oocytes
04/12/2006EP1645907A1 Protein-coated substrates and their preparation
04/12/2006EP1645635A2 Replication defective recombinant retroviruses expressing a palliative
04/12/2006EP1645634A2 Transgenic animal models for cardiac hypertrophy and uses thereof
04/12/2006EP1645631A2 Neisseria antigens and compositions
04/12/2006EP1645629A1 Human osteoclast-specific and related genes
04/12/2006EP1645566A2 Analogs of parathyroid hormone
04/12/2006EP1645563A1 Protein-refolding material
04/12/2006EP1645562A1 Ovary-specific genes and proteins
04/12/2006EP1645183A1 Process for producing human-origin immunocompetent cell
04/12/2006EP1644742A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1)
04/12/2006EP1644732A2 Animal model for the analysis of tumor metastasis
04/12/2006EP1644729A2 Anti-cd74 immunoconjugates and methods
04/12/2006EP1644528A2 Variants of human taste receptor genes